Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 145-156 of 2,031
Other study type icon
RecruitingNCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

This observational study is following people with major depression Depressive Episode, Depressive Symptoms, or Anhedonia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
San Francisco Veterans Affairs Medical Center
Condition
Depression
Drug study icon
RecruitingNCT06070766

RIVER At Home Ketamine Protocols

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Multiple locations, including Bigfork
Why is this study shown?

This study is directly about Depression.

Depression, PTSD, ...DrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
RIVER Foundation
Condition
Depression, PTSD, ...
Drug study icon
RecruitingNCT07645157

Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Chongqing
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 12 Years to 18 Years
Countries
China
Sponsor
First Affiliated Hospital of Chongqing Medical University
Condition
Depression
Drug study icon
RecruitingNCT04984512

Mitizodone Phosphate Tablets for depression

This study is recruiting in China. It is testing mitizodone Phosphate Tablets for depression.

In Dongguan
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Sunshine Lake Pharma Co., Ltd.
Condition
Depression
Drug study icon
RecruitingNCT06619366

The Impact of Coach-guided Risk Communication on the Risk of Major Depression

This study is looking at whether a digital support tool can help people with Major Depressive Episode, Risk Reduction, or Self Efficacy. Participants take part in a digital support tool and complete follow-up assessments.

In Halifax
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Dalhousie University
Condition
Depression
Other study type icon
RecruitingNCT07166289

Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

This study is looking at care and outcomes for people with Treatment-Resistant Depression. Some participants may receive Sham LIFU instead of the study treatment, and direct benefit is not guaranteed.

In Tulsa
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Device study icon
RecruitingNCT03887715

Effectiveness of VNS Therapy® System in treatment-resistant depression

This study is recruiting in the United States. It is testing VNS Therapy® System for treatment-resistant depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
LivaNova
Condition
Depression
Drug study icon
RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.

Multiple locations, including Tucson
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, Canada, ...
Sponsor
atai Therapeutics, Inc.
Condition
Depression
Drug study icon
RecruitingNCT07610473

Effectiveness of DT-101 in depression

This study is recruiting in the United States. It is testing DT-101 for depression.

Multiple locations, including DeSoto
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.